CompletedPhase 3NCT00554788
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
Studying Retinoblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Ira J Dunkel, MDChildren's Oncology Group
- Intervention
- Autologous Bone Marrow Transplantation(procedure)
- Enrollment
- 60 target
- Eligibility
- 10 years · All sexes
- Timeline
- 2008 – 2024
Study locations (30)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Phoenix Childrens Hospital, Phoenix, Arizona, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center, Downey, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
- UCSF Medical Center-Parnassus, San Francisco, California, United States
- UCSF Medical Center-Mission Bay, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, United States
- Connecticut Children's Medical Center, Hartford, Connecticut, United States
- Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00554788 on ClinicalTrials.govOther trials for Retinoblastoma
Additional recruiting or active studies for the same condition.